Loading...
Ginkgo Bioworks Holdings, Inc. WT
DNA-WT•NYSE
HealthcareBiotechnology
$0.27
$-0.01(-2.76%)
Ginkgo Bioworks Holdings, Inc. WT (DNA-WT) Financial Performance & Statements
Review Ginkgo Bioworks Holdings, Inc. WT’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-9.71%
↓ 9.71%
Operating Income Growth
35.24%
↑ 35.24%
Net Income Growth
38.73%
↑ 38.73%
Operating Cash Flow Growth
-8.15%
↓ 8.15%
Operating Margin
-198.27%
↓ 198.27%
Gross Margin
73.59%
↑ 73.59%
Net Profit Margin
-198.84%
↓ 198.84%
ROE
-63.06%
↓ 63.06%
ROIC
-39.97%
↓ 39.97%
Ginkgo Bioworks Holdings, Inc. WT (DNA-WT) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Ginkgo Bioworks Holdings, Inc. WT stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $43.85M | $89.05M | $56.21M | $37.94M |
| Cost of Revenue | $9.62M | $9.99M | $31.05M | $22.07M |
| Gross Profit | $34.23M | $79.06M | $25.16M | $15.87M |
| Gross Profit Ratio | $0.78 | $0.89 | $0.45 | $0.42 |
| R&D Expenses | $76.38M | $77.006M | $134.22M | $123.59M |
| SG&A Expenses | $57.30M | $52.29M | $66.28M | $51.02M |
| Operating Expenses | $137.83M | $134.26M | $267.34M | $174.61M |
| Total Costs & Expenses | $147.45M | $144.25M | $279.15M | $196.68M |
| Interest Income | $7.34M | $9.25M | $10.31M | $11.71M |
| Interest Expense | $94000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $15.65M | $17.17M | $17.33M | $12.87M |
| EBITDA | -$143.48M | -$35.93M | -$136.94M | -$165.13M |
| EBITDA Ratio | -$3.27 | -$0.40 | -$2.44 | -$3.84 |
| Operating Income | -$103.61M | -$55.20M | -$222.94M | -$158.74M |
| Operating Income Ratio | -$2.36 | -$0.62 | -$3.97 | -$4.18 |
| Other Income/Expenses (Net) | -$4.25M | -$1.57M | $5.95M | $12.12M |
| Income Before Tax | -$107.86M | -$56.78M | -$216.99M | -$165.88M |
| Income Before Tax Ratio | -$2.46 | -$0.64 | -$3.86 | -$4.37 |
| Income Tax Expense | -$325000.00 | -$375000.00 | $190000.00 | $31000.00 |
| Net Income | -$107.53M | -$56.40M | -$217.18M | -$165.91M |
| Net Income Ratio | -$2.45 | -$0.63 | -$3.86 | -$4.37 |
| EPS | -$2.07 | -$1.08 | -$4.23 | -$3.31 |
| Diluted EPS | -$2.07 | -$1.08 | -$4.23 | -$3.32 |
| Weighted Avg Shares Outstanding | $51.89M | $52.24M | $51.33M | $49.99M |
| Weighted Avg Shares Outstanding (Diluted) | $51.89M | $52.25M | $51.38M | $50.13M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan